News
Morgan Stanley sees a more "synchronous" earnings recovery for the U.S. ahead, aided by Fed rate cuts next year, dollar ...
Morgan Stanley turned bullish on most major U.S. assets, upgrading its stance on stocks and Treasuries to "overweight", ...
(Reuters) - Morgan Stanley upgraded its stance on U.S. equities to "overweight", citing a slowing but still expanding global ...
Morgan Stanley has raised its call on US stocks and Treasuries on expectations that a slew of future interest-rate cuts by ...
Moody's downgrade of U.S. debt is fueling concerns about investor appetite for U.S. government bonds, potentially driving ...
The debt downgrade is raising concerns that investors could reevaluate their appetite for U.S. government bonds, with the ...
Chris Toomey, Morgan Stanley managing director of private wealth, said in a latest program on CNBC that he is not bullish on stocks yet and plans to “stay defensive” until a few key issues are ...
Cognizant, which now shows FX-neutral organic growth in the range of 2.5% to 3%, is also gaining momentum, closing the ...
2d
InvestorsHub on MSNTesla valuation problem ’to get worse before it gets better’: Morgan StanleyTesla’s high market valuation remains difficult to justify and may become even harder to defend soon, according to Morgan ...
“When combined with the recent U.S. App Store injunction, up to 60% of Apple’s Services revenue is ’at risk’,” said Morgan ...
Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential ...
Astera Labs (ALAB) was in the spotlight on Monday as Morgan Stanley upgraded the semiconductor solutions company. Read for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results